204 related articles for article (PubMed ID: 37214445)
1. Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis.
Zhang Y; Lu L; Zheng R
Front Pharmacol; 2023; 14():1140771. PubMed ID: 37214445
[No Abstract] [Full Text] [Related]
2. A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011-2021.
Zhang H; Shi Y; Ying J; Chen Y; Guo R; Zhao X; Jia L; Xiong J; Jiang F
Front Endocrinol (Lausanne); 2023; 14():1164692. PubMed ID: 37152956
[TBL] [Abstract][Full Text] [Related]
3. Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors.
Zeng L; Ma G; Chen K; Zhou Q
Front Immunol; 2023; 14():1242336. PubMed ID: 37869006
[TBL] [Abstract][Full Text] [Related]
4. Immune-related adverse events: A bibliometric analysis.
Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
Front Immunol; 2022; 13():1096806. PubMed ID: 36591239
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors.
Tan Y; Song Q
Heliyon; 2024 Jan; 10(2):e24452. PubMed ID: 38293546
[TBL] [Abstract][Full Text] [Related]
6. Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis.
Xu Y; Jiang Z; Kuang X; Chen X; Liu H
J Med Internet Res; 2022 Jun; 24(6):e32728. PubMed ID: 35759331
[TBL] [Abstract][Full Text] [Related]
7. Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis.
Shen H; Li C
Front Oncol; 2024; 14():1385761. PubMed ID: 38817907
[TBL] [Abstract][Full Text] [Related]
8. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
9. A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
Miao L; Zhang J; Zhang Z; Wang S; Tang F; Teng M; Li Y
Front Immunol; 2022; 13():840956. PubMed ID: 35371087
[TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
11. Global research trends and focus on the link between colorectal cancer and gut flora: a bibliometric analysis from 2001 to 2021.
Chang Y; Ou Q; Zhou X; Liu J; Zhang S
Front Microbiol; 2023; 14():1182006. PubMed ID: 37213508
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China.
Xiong A; Wang J; Zhou C
Front Oncol; 2021; 11():757993. PubMed ID: 34900707
[TBL] [Abstract][Full Text] [Related]
13. Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022.
Xiao D; Li J; Liu Y; Wang T; Niu C; Zhuang R; Liu B; Ma L; Li M; Zhang L
Front Cardiovasc Med; 2023; 10():1089916. PubMed ID: 36960468
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis.
Chen X; He F; Zhang W; Fu Y; Cao Z
Front Oncol; 2023; 13():1092969. PubMed ID: 37124495
[TBL] [Abstract][Full Text] [Related]
15. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
16. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
17. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
18. Charting the course of ferroptosis research in lung cancer: Insights from a bibliometric analysis.
Zhou H; Mao Y; Zhou Z
Heliyon; 2024 Jan; 10(2):e24810. PubMed ID: 38312575
[TBL] [Abstract][Full Text] [Related]
19. Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis.
Yang Y; Wang F
Front Oncol; 2022; 12():983892. PubMed ID: 36465399
[TBL] [Abstract][Full Text] [Related]
20. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
Front Immunol; 2022; 13():975695. PubMed ID: 36148235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
